Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shexiang Baoxin Pill for chronic ischemic heart failure
ChiCTR-TRC-10001237Phase 4Completed
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Oct 2010
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ischaemic cardiomyopathy (ICM) comparing Shexiang Baoxin Pill group with Placebo group (2 arms). Primary endpoints: Composite endpoints and New York Heart Association functional class assessment. Started Oct 2010; status: completed.
02
Drugs
Shexiang Baoxin Pill
03
Conditions
ischaemic cardiomyopathy (ICM)
Beyond the preview
Go deeper on ChiCTR-TRC-10001237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10001237.